This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCracken, A A Articles by Brown, J L Search for Related Content PubMed PubMed Citation Articles by McCracken, A A Articles by Brown, J L

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 April; 9(4): 1406-1414

Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.

Department of Biology, University of Nevada-Reno 89557.

ABSTRACT

Human alpha-1-proteinase inhibitor (A1PI) deficiency, associated with the Z-variant A1PI (A1PI/Z) gene, results from defective secretion of the inhibitor from the liver. The A1PI/Z gene exhibits two point mutations which specify amino acid substitutions, Val-213 to Ala and Glu-342 to Lys. The functional importance of these substitutions in A1PI deficiency was investigated by studying the secretion of A1PI synthesized in COS cells transfected with A1PI genes altered by site-directed mutagenesis. This model system correctly duplicates the secretion defect seen in individuals homozygous for the A1PI/Z allele and shows that the substitution of Lys for Glu-342 alone causes defective secretion of A1PI. The substitution of Lys for Glu-342 eliminates the possibility for a salt bridge between residues 342 and 290, which may decrease the conformational stability of the molecule and thus account for the secretion defect. However, when we removed the potential to form a salt bridge from the wild-type inhibitor by changing Lys-290 to Glu (A1PI/SB-290Glu), secretion was not reduced to the 19% of normal level seen for A1PI/Z-342Lys; in fact, 75% of normal secretion was observed. When the potential for salt bridge formation was returned to A1PI/Z-342Lys by changing Lys-290 to Glu, only 46% of normal secretion was seen. These data indicate that the amino acid substitution at position 342, rather than the potential to form the 290-342 salt bridge, is the critical alteration leading to the defect in A1PI secretion.

This article has been cited by other articles:

• Scott, C. M., Kruse, K. B., Schmidt, B. Z., Perlmutter, D. H., McCracken, A. A., Brodsky, J. L. (2007). ADD66, a Gene Involved in the Endoplasmic Reticulum-associated Degradation of {alpha}-1-Antitrypsin-Z in Yeast, Facilitates Proteasome Activity and Assembly. Mol. Biol. Cell 18: 3776-3787 [Abstract] [Full Text]  
• Teter, K., Jobling, M. G., Holmes, R. K. (2004). Vesicular Transport Is Not Required for the Cytoplasmic Pool of Cholera Toxin To Interact with the Stimulatory Alpha Subunit of the Heterotrimeric G Protein. Infect. Immun. 72: 6826-6835 [Abstract] [Full Text]  
• Fingerhut, A., Reutrakul, S., Knuedeler, S. D., Moeller, L. C., Greenlee, C., Refetoff, S., Janssen, O. E. (2004). Partial Deficiency of Thyroxine-Binding Globulin-Allentown Is Due to a Mutation in the Signal Peptide. J. Clin. Endocrinol. Metab. 89: 2477-2483 [Abstract] [Full Text]  
• Lawless, M. W., Greene, C. M., Mulgrew, A., Taggart, C. C., O'Neill, S. J., McElvaney, N. G. (2004). Activation of Endoplasmic Reticulum-Specific Stress Responses Associated with the Conformational Disease Z {alpha}1-Antitrypsin Deficiency. J. Immunol. 172: 5722-5726 [Abstract] [Full Text]  
• Teter, K., Holmes, R. K. (2002). Inhibition of Endoplasmic Reticulum-Associated Degradation in CHO Cells Resistant to Cholera Toxin, Pseudomonas aeruginosa Exotoxin A, and Ricin. Infect. Immun. 70: 6172-6179 [Abstract] [Full Text]  
• Carrell, R. W., Lomas, D. A. (2002). Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases. NEJM 346: 45-53 [Full Text]